Artisan Small Cap Fund Sold Inspire Medical Systems (INSP) Amid Challenges

In its third-quarter 2025 capitalist letter, Artisan Small Cap Fund highlighted stocks specified arsenic Inspire Medical Systems, Inc. (NYSE:INSP). Inspire Medical Systems, Inc. (NYSE:INSP) is simply a aesculapian exertion institution that focuses connected the improvement and commercialization of minimally invasive solutions for patients with obstructive slumber apnea. The one-month instrumentality of Inspire Medical Systems, Inc. (NYSE:INSP) was 2.51%, and its shares mislaid 51.79% of their worth implicit the past 52 weeks. On November 17, 2025, Inspire Medical Systems, Inc. (NYSE:INSP) banal closed astatine $84.87 per share, with a marketplace capitalization of $2.51 billion.

Artisan Small Cap Fund stated the pursuing regarding Inspire Medical Systems, Inc. (NYSE:INSP) successful its 3rd 4th 2025 capitalist letter:

"We ended our concern campaigns in Inspire Medical Systems, Inc. (NYSE:INSP), Astera Labs and Clearwater Analytics during the quarter. Inspire Medical Systems is the US person successful hypoglossal nervus stimulation for slumber apnea, offering the lone FDA-approved alternate to continuous affirmative airway unit treatment. In precocious 2024, we reduced our presumption successful Inspire from the CropSM to the GardenSM owed to increasing concerns astir emerging competitory products. At the time, we believed that the recently launched Inspire V strategy would bring the institution lone to parity with immoderate of these entrants, making flawless execution of the rollout essential. This quarter, it became wide that the institution is facing important challenges with the launch. As a result, we exited our GardenSM position."

Inspire Medical Systems, Inc. (NYSE:INSP) is not connected our database of 30 Most Popular Stocks Among Hedge Funds. As per our database, 34 hedge money portfolios held Inspire Medical Systems, Inc. (NYSE:INSP) astatine the extremity of the 2nd quarter, which was 37 successful the erstwhile quarter. In Q3 2025, Inspire Medical Systems, Inc. (NYSE:INSP) reported gross of $224.5 million, an 10% summation from Q3 2024. While we admit the imaginable of Inspire Medical Systems, Inc. (NYSE:INSP) arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.